Unjha Formulations Limited has announced the appointment of Mr. Siddharth Shah as its new Company Secretary and Compliance Officer, effective October 1, 2025. The decision was made during a board meeting held on the same date, as disclosed in a regulatory filing to the Bombay Stock Exchange (BSE).

Key Appointment Details

Professional Background

Mr. Shah brings over five years of diverse professional experience to his new role at Unjha Formulations. His expertise spans several critical areas:

• Compliance
• Insolvency and Bankruptcy
• Finance
• Taxation
• Corporate Laws
• Valuation
• Audit
• Secretarial Compliances
• Due Diligence

Throughout his career, Mr. Shah has collaborated with Resolution Professionals, Liquidators, and Registered Valuers under the Insolvency and Bankruptcy Code (IBC), 2016. This experience has equipped him with a comprehensive understanding of complex corporate matters and the ability to provide both legal and financial solutions.

Appointment Process

The appointment of Mr. Siddharth Shah was made in accordance with:

• Section 203 of the Companies Act, 2013 and its associated rules
• Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Corporate Governance

This appointment underscores Unjha Formulations' commitment to maintaining strong corporate governance practices and ensuring compliance with regulatory requirements. As the Company Secretary and Compliance Officer, Mr. Shah will play a crucial role in overseeing the company's adherence to various statutory and regulatory obligations.

The board meeting that approved this appointment commenced at 3:30 PM and concluded at 4:00 PM on October 1, 2025.

Unjha Formulations Limited, headquartered in Sidhpur, North Gujarat, continues to strengthen its management team to support its business operations and maintain transparency with its stakeholders.

Unjha Formulations Limited announced its financial results for the first quarter, revealing a shift from profit to loss compared to the same period last year. The pharmaceutical company's performance was marked by decreased revenue and increased expenses, resulting in a net loss for the quarter.

Financial Highlights

• Net Loss: Rs. 40.64 lakhs, compared to a profit of Rs. 50.76 lakhs in the same quarter last year
• Total Income: Decreased to Rs. 363.40 lakhs from Rs. 395.43 lakhs year-over-year
• Total Expenses: Rose to Rs. 325.81 lakhs from Rs. 272.54 lakhs in the previous year
• Earnings Per Share (EPS): Negative Rs. 0.91, down from positive Rs. 1.56 in the same quarter last year

Detailed Financial Performance

Key Observations

1. Revenue Decline: The company experienced a decrease in total income, with net sales falling by 8.55% year-over-year.

2. Expense Management: Despite the revenue decline, total expenses remained relatively stable, increasing only marginally by 0.08%. However, there were significant changes in individual expense categories:

   • Cost of materials consumed decreased by 5.01%
   • Employee benefits expenses reduced by 24.64%
   • Other expenses saw a substantial increase of 76.79%

3. Profitability Impact: The combination of lower revenue and higher other expenses led to a significant swing in profitability, resulting in a net loss for the quarter.

4. EPS Decline: The earnings per share turned negative, reflecting the company's loss-making position in the current quarter.

The board of directors of Unjha Formulations Limited approved these unaudited financial results at their meeting. The meeting commenced at 12:05 a.m. and concluded at 1:00 p.m.

Investors and stakeholders will be closely watching the company's performance in the coming quarters to see if it can reverse this trend and return to profitability. The management may need to focus on cost optimization and revenue growth strategies to improve the company's financial health.